Unexplained weight loss (UWL), defined as a decrease of 5% or more in body weight over a period of 6 to 12 months without a clear cause, poses a significant diagnostic challenge in clinical practice. This article aims to provide a comprehensive approach to the evaluation and management of UWL.
UWL can be the result of a variety of underlying conditions, including gastrointestinal diseases, malignancies, endocrine disorders, mental health conditions, and infectious diseases. It can also be a side effect of certain medications. A thorough history and physical examination are crucial in identifying potential causes.
A stepwise approach is recommended for the evaluation of UWL. Initial investigations should include a comprehensive metabolic panel, complete blood count, thyroid function tests, and urinalysis. If these tests are inconclusive, further investigations such as imaging studies, endoscopy, or biopsy may be warranted based on the patient's symptoms and risk factors.
Management of UWL primarily involves treating the underlying condition. In cases where no clear cause is identified, a symptom-focused approach may be beneficial. This may include nutritional support, medication review, and psychological interventions. Regular follow-up is essential to monitor the patient's progress and reassess the diagnosis if necessary.
While UWL can be a perplexing diagnostic dilemma, a systematic and comprehensive approach can aid in the identification and management of the underlying cause. It is crucial for healthcare professionals to consider a broad differential diagnosis and to utilize appropriate diagnostic tools in a stepwise manner. Regular patient follow-up and reassessment are key in ensuring effective management and positive patient outcomes.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation